Join us for an interactive presentation by Arjun Balar, MD, as he guides us through his thought process for selecting optimal first-line therapy for patients with advanced urothelial carcinoma.
Join us for an interactive presentation by Arjun Balar, MD, as he discusses current treatment options for patients with advanced urothelial carcinoma after previous chemotherapy and immunotherapy.
Join us for an interactive presentation by Arjun Balar, MD, on the role of biomarkers in urothelial cancer management.
Join Arjun Balar, MD, for an interactive presentation on the role of immunotherapy in the management of localized urothelial cancer.
Join us for an interactive presentation by Kaitlyn Francese, MSN, RN, OCN, on the nurse’s role in managing immune-related adverse events associated with the use of immune checkpoint inhibitors in urothelial cancer.
Join us for an interactive presentation by Kaitlyn Francese, MSN, RN, OCN, discussing the risks and benefits of urothelial cancer treatments from the perspectives of the healthcare professional and the patient.
In this commentary, bladder cancer expert Matthew Galsky, MD, answers questions on the use of immune checkpoint blockade in first-line treatment, switch maintenance, and adjuvant therapy.
Download slides by Arjun Balar, MD on the role of immunotherapy and chemotherapy as first-line treatment for patients with advanced urothelial cancer.
Download slides by Arjun Balar, MD on the role of antibody-drug conjugates in advanced urothelial cancer following chemotherapy and immunotherapy.
Download slides by Arjun Balar, MD on the role of biomarkers in urothelial cancer management and selection for treatment approaches.
Download slides by Arjun Balar, MD on the role of immunotherapy in early stage urothelial cancer.
Download slides by Kaitlyn Francese, MSN, RN, OCN on the optimal management of immune-related AEs for patients with advanced urothelial cancer who are treated with immune checkpoint inhibitor therapy.
Download slides by Kaitlyn Francese, MSN, RN, OCN on considerations from patients’ perspectives for available treatment strategies for patients with advanced urothelial cancer.
Gain key clinical insights fast, with this short slideset from CCO on the current and emerging treatment options for patients with bladder cancer.
This Interactive Decision Support Tool will let you compare your choice of therapy for patients with advanced bladder cancer with expert recommendations from Matthew Galsky, MD; Shilpa Gupta, MD; Matthew I. Milowsky, MD; Elizabeth R. Plimack, MD, MS; and Arlene O. Siefker-Radtke, MD.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.